Wendy Chan
Chief Executive Officer at LODE GOLD RESOURCES INC.
Net worth: 42 320 $ as of 2024-03-30
Profile
Wendy T.
Chan is the founder of Moxie Strategy, Inc., Care Point Medical & Wellness Clinics.
She currently holds the position of Chief Executive Officer & Director at Lode Gold Resources, Inc. since 2023, Independent Director at Riverside Resources, Inc. since 2022, and Director at Mandala Capital, Inc. since 2022.
Previously, she worked as a Business Director at Johnson & Johnson, Janssen Pharmaceuticals, Inc., Aurora Cannabis, Inc., GlaxoSmithKline, Inc., and Janssen, Inc. She also served as a Director at Bc Cancer Foundation and held the position of Business Director at NexGen Hearing.
Additionally, she worked as the Vice President-Corporate Development at Skeena Resources Ltd.
Ms. Chan completed her MBA from McGill University and holds an undergraduate degree from the University of British Columbia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LODE GOLD RESOURCES INC
0.41% | 2024-03-03 | 900,000 ( 0.41% ) | 21 600 $ | 2024-03-30 |
MANDALA CAPITAL INC
6.15% | 2023-02-09 | 560,000 ( 6.15% ) | 20 720 $ | 2024-03-30 |
RIVERSIDE RESOURCES INC.
-.--% | 2024-01-16 | 0 ( -.--% ) | - $ | 2024-03-30 |
Wendy Chan active positions
| Companies | Position | Start |
|---|---|---|
| MANDALA CAPITAL INC. | Director/Board Member | 2022-04-30 |
| RIVERSIDE RESOURCES INC. | Director/Board Member | 2022-02-28 |
| LODE GOLD RESOURCES INC. | Chief Executive Officer | 2023-12-18 |
Former positions of Wendy Chan
| Companies | Position | End |
|---|---|---|
| Bc Cancer Foundation | Director/Board Member | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - |
NexGen Hearing
 NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Corporate Officer/Principal | - |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Training of Wendy Chan
| McGill University | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| SKEENA RESOURCES LIMITED | Non-Energy Minerals |
| RIVERSIDE RESOURCES INC. | Non-Energy Minerals |
| AURORA CANNABIS INC. | Process Industries |
| LODE GOLD RESOURCES INC. | Non-Energy Minerals |
| Private companies | 8 |
|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
| Bc Cancer Foundation | |
NexGen Hearing
NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Health Technology |
| Mandala Capital, Inc. | |
| Moxie Strategy, Inc. | |
| Care Point Medical & Wellness Clinics |
- Stock Market
- Insiders
- Wendy Chan
